Sophie-
I recommend you go talk to a radiation oncologist on your own. Is there any reason you need a referral from his Urologist to do that? His PSA at 6 weeks was well ahead of the level predictive of biochemical recurrence (see
the Veseley et al. study).
An interesting new study just
opened up at Washington U in St. Louis. They are using a new kind of PET scan to detect recurrences. It is an C-11 Choline PET/
MRI scan rather than a C-11 Choline PET/
CT scan. The switch to MRI may potentially make a big difference in getting down to a lower PSA detection limit. They are only requiring a PSA of 0.2 ng/ml on 2 subsequent tests after an RP. (This compares to a PSA of 2.0 ng/ml for even the most sensitive PET/CTs commercially available - which would be far too high). This also means that starting HT now would destroy any chances of such detection.
Below are the details of the study. There are contact details, so you can ask about
cost and whether he qualifies. Right now, it is the only one in the US that I'm aware of.
NCT02355054The advantage, of course, is if he is found to have only regional (pelvic area) recurrence, it can be treated and perhaps cured with adjuvant radiation. If it shows distant mets, lifelong hormone therapy is his best option. I think it's a lot better than using PSA alone as a gauge.
- Allen